JPS55153712A - Insulin pharmaceutical preparation and its production - Google Patents

Insulin pharmaceutical preparation and its production

Info

Publication number
JPS55153712A
JPS55153712A JP6129279A JP6129279A JPS55153712A JP S55153712 A JPS55153712 A JP S55153712A JP 6129279 A JP6129279 A JP 6129279A JP 6129279 A JP6129279 A JP 6129279A JP S55153712 A JPS55153712 A JP S55153712A
Authority
JP
Japan
Prior art keywords
acid
insulin
pharmaceutical preparation
excipien
tunica mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6129279A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5643443B2 (cg-RX-API-DMAC7.html
Inventor
Kenji Hara
Kyosaburo Tachibana
Seiji Naito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP6129279A priority Critical patent/JPS55153712A/ja
Priority to FR8010946A priority patent/FR2456522A1/fr
Priority to DE19803018843 priority patent/DE3018843A1/de
Publication of JPS55153712A publication Critical patent/JPS55153712A/ja
Publication of JPS5643443B2 publication Critical patent/JPS5643443B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP6129279A 1979-05-18 1979-05-18 Insulin pharmaceutical preparation and its production Granted JPS55153712A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP6129279A JPS55153712A (en) 1979-05-18 1979-05-18 Insulin pharmaceutical preparation and its production
FR8010946A FR2456522A1 (fr) 1979-05-18 1980-05-14 Composition d'insuline, son procede de preparation et son application en therapeutique
DE19803018843 DE3018843A1 (de) 1979-05-18 1980-05-16 Insulinpraeparat und verfahren zur herstellung desselben

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6129279A JPS55153712A (en) 1979-05-18 1979-05-18 Insulin pharmaceutical preparation and its production

Publications (2)

Publication Number Publication Date
JPS55153712A true JPS55153712A (en) 1980-11-29
JPS5643443B2 JPS5643443B2 (cg-RX-API-DMAC7.html) 1981-10-13

Family

ID=13166964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6129279A Granted JPS55153712A (en) 1979-05-18 1979-05-18 Insulin pharmaceutical preparation and its production

Country Status (3)

Country Link
JP (1) JPS55153712A (cg-RX-API-DMAC7.html)
DE (1) DE3018843A1 (cg-RX-API-DMAC7.html)
FR (1) FR2456522A1 (cg-RX-API-DMAC7.html)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
JPS56138112A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing ascorbic acid or sodium ascorbate
JPS5780315A (en) * 1980-11-09 1982-05-19 Kyoto Yakuhin Kogyo Kk Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum
JPS5838210A (ja) * 1981-08-31 1983-03-05 Taiho Yakuhin Kogyo Kk 直腸投与用製剤
JPS60197618A (ja) * 1984-03-19 1985-10-07 Taiyo Kagaku Kk 坐薬用医薬組成物
JPS62158207A (ja) * 1986-01-06 1987-07-14 Showa Yakuhin Kako Kk 直腸投与用組成物
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
JPS61138863A (ja) * 1984-12-11 1986-06-26 Honda Motor Co Ltd 内燃機関の機関本体
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
CA2502986C (en) 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
CA2780043C (en) 2009-11-13 2019-01-29 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist and methionine
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL45481C (cg-RX-API-DMAC7.html) * 1900-01-01
JPS5315412A (en) * 1976-07-27 1978-02-13 Ono Pharmaceut Co Ltd Suppository for diabetics
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
JPS56138112A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing ascorbic acid or sodium ascorbate
JPS5780315A (en) * 1980-11-09 1982-05-19 Kyoto Yakuhin Kogyo Kk Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum
JPS5838210A (ja) * 1981-08-31 1983-03-05 Taiho Yakuhin Kogyo Kk 直腸投与用製剤
JPS60197618A (ja) * 1984-03-19 1985-10-07 Taiyo Kagaku Kk 坐薬用医薬組成物
JPS62158207A (ja) * 1986-01-06 1987-07-14 Showa Yakuhin Kako Kk 直腸投与用組成物
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents

Also Published As

Publication number Publication date
JPS5643443B2 (cg-RX-API-DMAC7.html) 1981-10-13
FR2456522A1 (fr) 1980-12-12
DE3018843A1 (de) 1980-11-20

Similar Documents

Publication Publication Date Title
JPS55153712A (en) Insulin pharmaceutical preparation and its production
JPS53109555A (en) Preparation of modified keratin-containing material
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS5350316A (en) Drug composition for oral administration
JPS5661311A (en) Thial amide or prolonged pharmaceutical preparation comprising its salt
JPS549240A (en) New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component
JPS5391125A (en) Insectcides composition containing chrysanthemumic acid esters and process for their preparation
JPS55122715A (en) Antidiabetic agent
JPS57193473A (en) Vitamin e linoleic acid ester
JPS5231024A (en) Process for preparation of epoxysuccinic acid esters
JPS5242815A (en) Process for preparation of carboxylic acid esters
JPS5283412A (en) Preparation of 3,3-dimethyl-4-pentenoic acids
JPS5612309A (en) Oral drug containing ubidecarenone
ES483463A1 (es) Procedimiento de preparacion de los esteres del 1-metil-4- piperidinol
JPS5283411A (en) Preparation of 3,3-dimethyl-4-pentenoic acid and its derivatives
JPS5283413A (en) Preparation of 3,3-dimethyl-4-pentenoic acid or its esters
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
JPS536414A (en) Carboxylic acid aluminum salts and their preparation
JPS5318586A (en) Preparation of 5-fluorouracils
JPS5365867A (en) Preparation of chenodeoxycholic acid crystal
JPS5246013A (en) Process for preparation of gamma-unsaturated carboxylic acid esters
JPS53149939A (en) Novel benzyl alcohol derivatives and their preparation
JPS5594317A (en) Antifungal agent
JPS5248640A (en) Process for preparation of alpha-substituted-phenyl-alkane-carboxylic acids their derivatives
JPS5368768A (en) Preparation of gamma-lactone